The Quality Lowdown: Moderna, Novartis, Dr. Reddys Confront Challenges

Leading edge products like mRNA vaccines and CAR-T therapies are not immune from quality problems, nor are immunosuppressives, as US FDA inspections and internal investigations recently found.